Morphine and MK-801 administration leads to alternative N-methyl-d-aspartate receptor 1 splicing and associated changes in reward seeking behavior and nociception on an operant orofacial assay

Neuroscience

Volumn 214, Issue , 2012, Pages 14-27

  Anderson, E M ^b   Del Valle Pinero, A Y ^b   Suckow, S K ^b   Nolan, T A ^c   Neubert, J K ^c   Caudle, R M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Accumbens; Amygdala; Hippocampus; Morphine; NMDA; Pain

Indexed keywords

DIZOCILPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; LATENT PERIOD; MALE; MENTAL PERFORMANCE; MILK; MOTIVATION; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NOCICEPTION; NONHUMAN; NUCLEUS ACCUMBENS; PHYSICAL TOLERANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RAT; REWARD; SWEETNESS; TEMPERATURE SENSITIVITY; THERMAL STIMULATION; WEIGHT GAIN; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; CONDITIONING, OPERANT; DIZOCILPINE MALEATE; DRUG THERAPY, COMBINATION; FACIAL PAIN; MALE; MORPHINE; MOTIVATION; NOCICEPTION; RATS; RATS, HAIRLESS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REWARD;

EID: 84861832780     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.04.032     Document Type: Article

References (53)

1. Buffalo E.A., Gillam M.P., Allen R.R., Paule M.G. Acute behavioral effects of MK-801 in rhesus monkeys: assessment using an operant test battery. Pharmacol Biochem Behav 1994, 48:935-940.
2. Burns G.A., Ritter R.C. The non-competitive NMDA antagonist MK-801 increases food intake in rats. Pharmacol Biochem Behav 1997, 56:145-149.
3. Carlezon W.A., Wise R.A. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 1993, 620:339-342.
4. Carlezon W.A., Kosten T.A., Nestler E.J. Behavioral interactions caused by combined administration of morphine and MK-801 in rats. Psychopharmacology (Berl) 2000, 151:261-272.
5. Carlsson M., Svensson A. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Sci 1990, 47:1729-1736.
6. Carr K.D., Kutchukhidze N. Effect of chronic food restriction on Fos-like immunoreactivity (FLI) induced in rat brain regions by intraventricular MK-801. Brain Res 2000, 873:283-286.
7. Caudle R.M., Perez F.M., Valle-Pinero A.Y., Iadarola M.J. Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation. Mol Pain 2005, 1:25.
8. Compton P.A., Ling W., Torrington M.A. Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients. Addict Biol 2008, 13:393-402.
9. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE re16.
10. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol Rev 1999, 51:7-61.
11. Galer B.S., Lee D., Ma T., Nagle B., Schlagheck T.G. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 2005, 115:284-295.
12. Glass M.J., Hegarty D.M., Oselkin M., Quimson L., South S.M., Xu Q., Pickel V.M., Inturrisi C.E. Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice. Exp Neurol 2008, 213:57-70.
13. Gracy K.N., Svingos A.L., Pickel V.M. Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J Neurosci 1997, 17:4839-4848.
14. Katsuura Y., Heckmann J.A., Taha S.A. Mu-Opioid receptor stimulation in the nucleus accumbens elevates fatty tastant intake by increasing palatability and suppressing satiety signals. Am J Physiol Regul Integr Comp Physiol 2011, 301:R244-R254.
15. King C.D., Devine D.P., Vierck C.J., Mauderli A., Yezierski R.P. Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience 2007, 147:174-182.
16. Kozela E., Popik P. A complete analysis of NMDA receptor subunits in periaqueductal grey and ventromedial medulla of morphine tolerant mice. Drug Alcohol Depend 2007, 86:290-293.
17. Le Greves P., Huang W., Zhou Q., Thornwall M., Nyberg F. Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypothalamus and spinal cord. Eur J Pharmacol 1998, 341:161-164.
18. Lee J.A., Xing Y., Nguyen D., Xie J., Lee C.J., Black D.L. Depolarization and CaM kinase IV modulate NMDA receptor splicing through two essential RNA elements. PLoS Biol 2007, 5:e40.
19. Loftis J.M., Janowsky A. Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit. Psychopharmacology (Berl) 2002, 164:349-359.
20. Manning B.H., Mao J., Frenk H., Price D.D., Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 1996, 67:79-88.
21. Martin G., Guadano-Ferraz A., Morte B., Ahmed S., Koob G.F., de Lecea L., Siggins G.R. Chronic morphine treatment alters N-methyl-d-aspartate receptors in freshly isolated neurons from nucleus accumbens. J Pharmacol Exp Ther 2004, 311:265-273.
22. Morgan D., Carter C.S., DuPree J.P., Yezierski R.P., Vierck C.J. Evaluation of prescription opioids using operant-based pain measures in rats. Exp Clin Psychopharmacol 2008, 16:367-375.
23. Mu Y.Y., Otsuka T., Horton A.C., Scott D.B., Ehlers M.D. Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors. Neuron 2003, 40:581-594.
24. Murray F., Harrison N.J., Grimwood S., Bristow L.J., Hutson P.H. Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats. Eur J Pharmacol 2007, 562:191-197.
25. Neubert J.K., Rossi H.L., Malphurs W., Vierck C.J., Caudle R.M. Differentiation between capsaicin-induced allodynia and hyperalgesia using a thermal operant assay. Behav Brain Res 2006, 170:308-315.
26. Neubert J.K., Widmer C.G., Malphurs W., Rossi H.L., Vierck C.J., Caudle R.M. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 2005, 116:386-395.
27. Okabe S., Miwa A., Okado H. Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit. J Neurosci 1999, 19:7781-7792.
28. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA.
29. Prybylowski K.L., Grossman S.D., Wrathall J.R., Wolfe B.B. Expression of splice variants of the NR1 subunit of the N-methyl-d-aspartate receptor in the normal and injured rat spinal cord. J Neurochem 2001, 76:797-805.
30. Rasmussen K., Brodsky M., Inturrisi C.E. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal. Synapse 1995, 20:68-74.
31. Scott D.B., Blanpied T.A., Swanson G.T., Zhang C., Ehlers M.D. An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J Neurosci 2001, 21:3063-3072.
32. Shimoyama N., Shimoyama M., Davis A.M., Monaghan D.T., Inturrisi C.E. An antisense oligonucleotide to the N-methyl-d-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance. J Pharmacol Exp Ther 2005, 312:834-840.
33. Suzuki M., Kinoshita T., Kikutani T., Yokoyama K., Inagi T., Sugimoto K., Haraguchi S., Hisayoshi T., Shimada Y. Determining the plasma concentration of ketamine that enhances epidural bupivacaine-and-morphine-induced analgesia. Anesth Analg 2005, 101:777-784.
34. Taha S.A., Katsuura Y., Noorvash D., Seroussi A., Fields H.L. Convergent, not serial, striatal and pallidal circuits regulate opioid-induced food intake. Neuroscience 2009, 161:718-733.
35. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991, 251:85-87.
36. Ueda H., Ueda M. Mechanisms underlying morphine analgesic tolerance and dependence. Front Biosci 2009, 14:5260-5272.
37. Vincler M., Maixner W., Vierck C.J., Light A.R. Effects of systemic morphine on escape latency and a hindlimb reflex response in the rat. J Pain 2001, 2:83-90.
38. Wadhwa A., Clarke D., Goodchild C.S., Young D. Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery. Anesth Analg 2001, 92:448-454.
39. Weinbroum A.A., Gorodetzky A., Nirkin A., Kollender Y., Bickels J., Marouani N., Rudick V., Meller I. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study. Cancer 2002, 95:1164-1170.
40. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?. Drugs 1998, 55:1-4.
41. Winkler A., Mahal B., Kiianmaa K., Zieglgansberger W., Spanagel R. Effects of chronic alcohol consumption on the expression of different NR1 splice variants in the brain of AA and ANA lines of rats. Brain Res Mol Brain Res 1999, 72:166-175.
42. Winkler A., Mahal B., Zieglgansberger W., Spanagel R. Accurate quantification of the mRNA of NMDAR1 splice variants measured by competitive RT-PCR. Brain Res Brain Res Protoc 1999, 4:69-81.
43. Xie J.Y. Control of alternative pre-mRNA splicing by Ca++ signals. Biochim Biophys Acta-Gene Regulatory Mechanisms 2008, 1779:438-452.
44. Yonghui L., Xigeng Z., Yunjing B., Xiaoyan Y., Nan S. Opposite effects of MK-801 on the expression of food and morphine-induced conditioned place preference in rats. J Psychopharmacol 2006, 20:40-46.
45. Zarrindast M.R., Asadi F., Rezayof A. Repeated pretreatment of morphine prevents morphine-induced amnesia: a possible involvement for dorsal hippocampal NMDA receptors. Arch Iran Med 2011, 14:32-38.
46. Zarrindast M.R., Lashgari R., Rezayof A., Motamedi F., Nazari-Serenjeh F. NMDA receptors of dorsal hippocampus are involved in the acquisition, but not in the expression of morphine-induced place preference. Eur J Pharmacol 2007, 568:192-198.
47. Zhang M., Kelley A.E. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology (Berl) 2002, 159:415-423.
48. Zhou F.C., Anthony B., Dunn K.W., Lindquist W.B., Xu Z.C., Deng P. Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res 2007, 1134:148-161.
49. Zhou Q., Price D.D., Caudle R.M., Verne G.N. Spinal NMDA NR1 subunit expression following transient TNBS colitis. Brain Res 2009, 1279:109-120.
50. Zhu H., Ho I.K. NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine. Eur J Pharmacol 1998, 352:151-156.
51. Zhu H., Jang C.G., Ma T., Oh S., Rockhold R.W., Ho I.K. Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment. Eur J Pharmacol 1999, 365:47-54.
52. Zhu H.B., Brodsky M., Gorman A.L., Inturrisi C.E. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614. Mol Brain Res 2003, 114:154-162.
53. Zukin R.S., Bennett M.V. Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 1995, 18:306-313.